Quantum Computing Inc. reports Thursday with one of the most extreme short-side setups on Nasdaq — a borrow market that has essentially no room left, sitting alongside a still-bullish analyst community and options traders leaning notably toward calls.
The borrow picture is the sharpest signal heading into the print. Availability has been at or near zero for virtually the entire past six weeks — every share in the lending pool is already lent out, and that has held even as short interest has edged slightly lower. Short sellers currently hold 27.4% of the free float, down modestly from a peak near 30% in mid-July but still one of the heaviest short positions on the exchange. Cost to borrow has settled around 12.7%, down from a July peak above 16% but still elevated. With zero availability and days-to-cover near 6.7, any sharp upside move in the stock would meet a structurally thin lending market. The ORTEX short score sits at 76.8, ranking in the 1st percentile of the universe — short pressure is extreme by almost any measure.
Options positioning tells a different story. The put/call ratio has dropped to 0.65, nearly 1.7 standard deviations below its 20-day average of 0.71 — the lowest it has been in months and approaching the 52-week low of 0.53. That means options flow has actually tilted toward calls ahead of earnings, suggesting at least part of the market is positioned for an upside surprise rather than bracing for a miss. The stock has recovered 2.2% on the week to $8.93, recovering from a 2.7% dip on Monday.
The bull-bear divide among analysts is unusually wide. The most recent analyst action of note came from Wedbush on August 3, when Matt Bryson assumed coverage with a Neutral rating and a $12 target — roughly 34% above the current price, but well below the bull camp. Rosenblatt continues to carry a Buy with a $22 target, and Ascendiant Capital raised its target to $30 in June, citing photonics-based quantum advantage and the acquisitions of NHanced Semiconductor and Luminar's fab business as near-term catalysts. Bears counter with the fundamentals: the company is deeply loss-making (EPS yield of -4%), revenue is tiny despite extraordinary headline growth from a near-zero base, and IBM and Google remain formidable competition on a much longer timeline to commercialisation. The mean analyst price target of $18.33 implies more than 100% upside from current levels — a gap that reflects genuine uncertainty rather than consensus conviction. The price-to-book sits at 2.3x, while EV/EBITDA is deeply negative, meaning the valuation is entirely a function of the option value placed on quantum technology eventually delivering commercial scale.
Institutional flows add a layer of nuance. BlackRock added 1.65 million shares in its most recent filing, while Penserra Capital rebuilt its position from scratch, adding 3.4 million shares. Vanguard Capital Management also initiated a new position. Against that, the largest individual holder, Yuping Huang, trimmed slightly. The pattern suggests index and passive vehicles are accumulating as the float grows, while the short base remains firmly entrenched.
Thursday's print is less a test of whether QUBT is growing — it is — and more a test of whether that growth is converting into anything that justifies the gap between a $9 stock and analyst targets ranging from $10 to $30, against a borrow market where bears have no room left to add.
See the live data behind this article on ORTEX.
Open QUBT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
